Attention-deficit/hyperactivity disorder

  title={Attention-deficit/hyperactivity disorder},
  author={Stephen V. Faraone and Philip J Asherson and Tobias Banaschewski and Joseph Biederman and Jan K. Buitelaar and Josep Antoni Ramos-Quiroga and Luis Augusto Rohde and Edmund J. S. Sonuga-Barke and Rosemary Tannock and Barbara Franke},
  journal={Nature Reviews Disease Primers},
Attention-deficit/hyperactivity disorder (ADHD) is a persistent neurodevelopmental disorder that affects 5% of children and adolescents and 2.5% of adults worldwide. Throughout an individual's lifetime, ADHD can increase the risk of other psychiatric disorders, educational and occupational failure, accidents, criminality, social disability and addictions. No single risk factor is necessary or sufficient to cause ADHD. In most cases ADHD arises from several genetic and environmental risk factors… 

ADHD across the lifespan

New findings on attention/hyperactivity disorder: what is (not) known?

Attention deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder which is characterized by inattention, hyperactivity and/or impulsivity. It affects roughly one out of twenty children

An overview on neurobiology and therapeutics of attention-deficit/hyperactivity disorder

An updated outline that addresses the etiological and neurobiological aspects of ADHD and its treatment, considering the impact of the “omics” era on disentangling the multifactorial architecture of ADHD.

Attention Deficit Hyperactivity Disorder

Attention deficit hyperactivity disorder.

Attention-Deficit/Hyperactivity Disorder Predominantly Inattentive Subtype/Presentation: Research Progress and Translational Studies

The Research Domain Criteria has been proposed to provide a novel framework for understanding the nature of neuropsychiatric illnesses and ultimately improve their diagnosis and treatment.

Shared genetic background between children and adults with attention deficit/hyperactivity disorder

It is confirmed that persistent ADHD in adults is a neurodevelopmental disorder and the existing hypothesis of a shared genetic architecture underlying ADHD and different traits to a lifespan perspective is extended.

Management of anxiety disorders in children with attention-deficit hyperactivity disorder: a narrative review

Adjunctive cognitive-behavior therapy for anxiety disorder symptoms is strongly recommended and is considered superior to medication alone, and in moderate and severe cases of comorbid Ads, selective serotonin reuptake inhibitors can be added to the stimulants, with the required caution.



ADHD: Prevalence, Diagnosis, and Issues of Comorbidity

  • T. Wilens
  • Psychology, Medicine
    CNS Spectrums
  • 2007
Acute and long-term use of long-acting stimulant formulations (methylphenidate and amphetamine compounds) have shown robust efficacy and tolerability consistent with the treatment response established in children with ADHD, and non-stimulant medications have demonstrated efficacy as well, and may be preferred in patients with tic and substance use disorders.

Is adult attention deficit hyperactivity disorder a valid diagnosis in the presence of high IQ?

It is suggested that adults with ADHD and a high IQ display patterns of functional impairments, familiality and psychiatric co-morbidities that parallel those found in the average-IQ adult ADHD population.

Diagnosis and evaluation of adults with attention-deficit/hyperactivity disorder.

  • L. AdlerJ. Cohen
  • Psychology, Medicine
    The Psychiatric clinics of North America
  • 2004

[Attention deficit hyperactivity disorder in adults. An overview].

Current results of epidemiology, etiology, clinical symptoms and comorbidity, diagnostic assessment, pharmacotherapy, and psychological interventions for adults with ADHD are discussed.

Patterns of psychiatric comorbidity, cognition, and psychosocial functioning in adults with attention deficit hyperactivity disorder.

The results show that referred and nonreferred adults with attention deficit hyperactivity disorder have a pattern of demographic, psychosocial, psychiatric, and cognitive features that mirrors well-documented findings among children with the disorder.

Separation of cognitive impairments in attention-deficit/hyperactivity disorder into 2 familial factors.

The findings suggest the existence of 2 familial pathways to cognitive impairments in ADHD and indicate promising cognitive targets for future molecular genetic investigations.

Attention-deficit/hyperactivity disorder and risk of substance use disorder: developmental considerations, potential pathways, and opportunities for research.

These opportunities to explain attention-deficit/hyperactivity disorder (ADHD)-related risk of substance use disorder (SUD) remain available for study by considering characteristics of children with ADHD and factors affecting their outcomes side by side with overlapping variables in the developmental literature on SUD etiology.

Medication for attention deficit-hyperactivity disorder and criminality.

It is raised the possibility that the use of medication reduces the risk of criminality among patients with ADHD, and rates of criminality were lower during periods when they were receiving ADHD medication.

Does childhood attention-deficit/hyperactivity disorder predict risk-taking and medical illnesses in adulthood?